Embecta (Nasdaq:EMBC) today revealed its phased plan to create value and shift priorities toward broader medical applications ...

Senseonics (NYSE:SENS) announced that it closed its previously announced public offering and private placement with Abbott.

Sequel Med Tech announced today that it agreed to integrate its twiist automated insulin delivery system with a future Abbott ...

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.

Tandem Diabetes Care (Nasdaq:TNDM) filed an SEC Form 8-K to state that it received CE mark for its Mobi insulin delivery ...

Glooko announced today that it expanded the position of Dr. Mark Clements to make him its chief medical and strategy officer.

Senseonics (NYSE:SENS) announced today that it commenced an underwritten public offering of common stock worth $50 million.

Abbott today announced results from real-world studies demonstrating benefits with its FreeStyle Libre CGM technology.

BD (NYSE:BDX) filed a lawsuit in a U.S. District Court alleging patent infringement by Baxter (NYSE:BAX) related to infusion ...

Go-Pen ApS announced recently that it received FDA 510(k) clearance for its Go-Pen cost-effective, user-filled insulin pen.